Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo

Nature Medicine

Volumn 5, Issue 6, 1999, Pages 662-668

  Sethi, Tariq ^a   Rintoul, Robert C ^a   Moore, Sarah M ^a   MacKinnon, Alison C ^a   Salter, Donald ^a   Choo, Chin ^a   Chilvers, Edwin R ^c   Dransfield, Ian ^a   Donnelly, Seamas C ^a   Strieter, Robert ^b   Haslett, Christopher ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; INTEGRIN; SCLEROPROTEIN;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL ADHESION; CELL SURVIVAL; EXTRACELLULAR MATRIX; LUNG SMALL CELL CANCER; METASTASIS; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

AMINO ACID CHLOROMETHYL KETONES; ANTIGENS, CD29; ANTINEOPLASTIC AGENTS; APOPTOSIS; BRADYKININ; CARCINOMA, SMALL CELL; CASPASE 3; CASPASES; CELL ADHESION; CELL DIVISION; COLLAGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; ETOPOSIDE; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; GALANIN; HUMANS; LAMININ; LUNG NEOPLASMS; PROTEIN-TYROSINE KINASES; TENASCIN; TUMOR CELLS, CULTURED; TYRPHOSTINS;

EID: 0033032317     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/9511     Document Type: Article

References (40)

1. th edn. (eds. De Vita, V.T. Jr, Hellman, S. and Rosenberg, S.A.) 591-687 (J.B. Lippincott, Philadelphia, 1993).
2. Smyth, J.F. et al. The impact of chemotherapy on small cell carcinoma of the bronchus. Q. J. Med. 61, 969-976 (1986).
3. Meredith, J.E. Jr., Fazeli, B. & Schwartz, M.A. The extracellular matrix as a cell survival factor. Mol. Biol. Cell 4, 953-961 (1993).
4. Frisch, S.M. & Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124, 619-626 (1994).
5. Meredith, J.E. Jr. & Schwartz, M.A. Integrins adhesion and apoptosis. Trends Cell Biol. 7, 146-150 (1997).
6. Boudreau, N., Sympson, C.J., Werb, Z. & Bissell, M.J. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267, 891-893 (1995).
7. Freedman, V.H. & Shin, S. Cellular tumorigenicity in nude mice, correlation with cell growth in semi-solid medium. Cell 3, 355-359 (1974).
8. Smith, P.J. et al. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small cell lung cancer cells. Br. J. Cancer 70, 914-921 (1994).
9. Aas, T. et al. Specific p53 mutations are associated with de nova resistance to doxorubicin in breast cancer patients. Nature Med. 2, 811-814 (1996).
10. Tallet, A. et al. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells. Cancer Res. 56, 4255-4263 (1996).
11. Sethi, T., Langdon, S., Smyth, J. & Rozengurt, E. Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Res. 52, 2737s-2742s (1992).
12. Langdon, S.P., Cummings, J. & Smyth, J.F. Antagonists of mitogenic peptides. Cancer Topics 9, 10-13 (1994).
13. Kelly, M.J. et al. Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer. Chest 112, 256-261 (1997).
14. Haynes, R.O. Integrins: Versatility and signaling in cell adhesion. Cell 69, 11-25 (1992).
15. Elices, M.J., Urry, L.A. & Hemler, M.E. Receptor functions for the integrin VLA-3: Fibronectin, collagen and laminin binding are differentially influenced by ARG-GLY-ASP peptide and by divalent cations. J. Cell Biol. 112, 169-181 (1991).
16. Vogel, B.E., Tarone, G., Giancotti, F.G., Gailit, J. & Ruoslahti, E. A novel fibronectin receptor with an unexpected subunit composition (ανβ1). J. Biol. Chem. 265, 5934-5937 (1990).
17. Falcioni, R. et al. Expression of β1, β3, β4 and β5 integrins by Human Lung Carcinoma cells of different histotypes. Exp. Cell Res. 210, 113-122 (1994).
18. Carney, D.N., Gazdar, A.F. & Minna, J.D. Positive correlation between histological tumor involvement and generation of tumor cell colonies in agarose in specimens taken directly from patients with small-cell carcinoma of the lung. Cancer Res. 40, 1820-1823 (1980).
19. Giaccone, G. Small cell lung cancer and topoisomerases. Anticancer Res. 14, 269-276 (1994).
20. Sakahira, H., Enari, M. & Nagata, S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391, 96-99 (1998).
21. Enari, M. et al. A caspase-activated DNAase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43-50 (1998).
22. Sentman, C.L., Shutter, J.R., Hockenbery, D., Kanagawa, O. & Korsmeyer, S.J. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67, 879-888 (1991).
23. Chinnaiyan, A.M. et al. Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem. 271, 4573-4576 (1996).
24. Sethi, T & Rozengurt, E. Multiple neuropeptides stimulate clonal growth of small cell lung cancer: effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin. Cancer Res. 51, 3621-3623 (1991).
25. Bepler, G. et al. Peptides and growth factors in small cell lung cancer: production, binding sites, and growth effects. Cancer Res. Clin. Oncol. 114, 235-244 (1988).
26. Rozengurt, E. Neuropeptides as cellular growth factors: role of multiple signaling pathways. Eur. J. Clin. Invest. 21, 123-134 (1991).
27. Arenberg, D.A. et al. Inhibition of interleukin-8 reduces tumourigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest. 97, 2792-2802 (1996).
28. Borsi, L., Castellani, P., Risso, A.M., Leprini, A. & Zardi, L. Transforming growth factor-β regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS Lett. 261, 175-178 (1990).
29. Sieweke, M.H., Thompson, N.L., Sporn, M.B. & Bissell, M.J. Mediation of wound-related Rous Sarcoma virus tumourigenesis by TCF-β. Science 48, 1656-1660 (1990).
30. Bloch, W. et al. β1 integrin is essential for teratoma growth and angiogenesis. J. Cell Biol. 139, 265-278 (1997).
31. Nicolò, G. et al. Expression of tenascin and of the ED-B containing oncofetal fibronectin isoform in human cancer. Cell Diff. Dev. 32, 401-408 (1990).
32. Hedin, U., Holm, J. & Hansson, G.K. Induction of tenascin in rat arterial injury: relationship to altered smooth muscle cell phenotype. Am. J. Pathol. 139, 649-656 (1991).
33. 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J. Cell Biol. 139, 279-293 (1997).
34. Lai, S.L. et al. MDR1 gene expression in lung cancer. J. Natl. Cancer Inst. 81, 1144-1150 (1989).
35. Fridman, R. et al. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorgenicity and the drug resistance of small cell lung cancer cell lines. Proc. Natl. Acad. Sci. USA 87, 6698-6702 (1990).
36. McCarthy, J.B., Barara, M.L., Palm, S.L., Sas, D.F. & Furcht, L.T. The role of cell adhesion proteins-laminin and fibronectin-in the movement of malignant and metastatic cells. Cancer Metastasis Rev. 4, 125-152 (1985).
37. Suzuki, J., Kaziro, Y., & Koide, H. Synergistic action of R-Ras and IGF-1 on Bcl-xL expression and caspase-3 inhibition in BaF3 cells: R-Ras and IGF-1 control distinct anti-apoptotic kinase pathways. FEBS Lett. 437, 112-116 (1998).
38. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P.H., & Downward, J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16, 2783-2793 (1997).
39. Duke R.C. & Cohen, J.J. in Current Protocols in Immunology (eds. Coligan, J.E. et al.) 3.17.1-3.17.16 (John Wiley & Sons, New York, 1992).
40. Staal, F.J.T., Roederer, M., Herzenberg L.A. & Herzenberg L.A. Intracellular thiols regulate activation of nuclear kB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 87, 9943-9947 (1990).